Latest Breaking News On - Reshape lifesciences inc - Page 1 : comparemela.com

GLP-1 not all loss, sweet side emerges for med tech

Investors bailed on many med-tech companies last year, fearing that the frenzy surrounding GLP-1 agonists would tank companies in the weight-loss, diabetes and orthopedics segments. Their concerns now appear overblown in many instances, with some of the most directly affected businesses reporting a “rising tide” associated with an increased focus on obesity treatment that has lifted their boats rather than sinking them.

Bioworld medtechZimmer biomet holdings incStryker corpAbbott laboratories incDexcom incReshape lifesciences incInsulet corpTandem diabetes care incAllurion technologies incGlp 1Endocrine metabolic

ReShape Lifesciences stock soars as obesity treatment gets FDA greenlight

ReShape Lifesciences stock soars as obesity treatment gets FDA greenlight
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Christine renPaul hickeyDrug administrationLifesciences incGrossman school of medicineReshape lifesciences incChristine ren fieldingBariatric surgery

Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket - 180 Life Sciences (NASDAQ:ATNF), Altisource Asset Mgmt (AMEX:AAMC)

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading.

Mymd pharmaceuticals incWuhan sendcloud technology co ltdMymd pharmaceuticalsLifesciences incHoldings limitedNextplay technologies incPetros pharmaceuticalsPetros pharmaceuticals incMuhua information technology co ltdJin medical international ltdShengfeng development limitedWang lee group incAltisource asset management corporationNuburu incGlobal incEdesa biotech inc

Public Companies Quarterly Update (Q3 2023) | Saul Ewing LLP

Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies.

United statesOfferingof nftsHesterm peirceMarkt uyedaDistrict of columbia courtOmnia wellness incUs supreme courtSaul ewingLandmark court rulingChinese communist partySecurities exchangePegasystems incCity of fort lauderdale policeGrayscale investmentsExchange commissionDivision of corporation

ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System

Royalty-Bearing License Agreement Covers the Countries in the Indian Subcontinent, Representing Approximately 20% to 25% of the World’s PopulationIRVINE, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of an exclusive, royalty-bearing license agreement with Biorad Medysis, Pvt. Ltd. (Biorad) to manufacture, commercialize and distribute the Obalon® Gastric

Sri lankaUnited statesPaulf hickeyMichael millerBiorad medysisThomas stankovichExchange commissionLifesciences incRx communications groupDrug administrationRoyalty bearing license agreement coversIndian subcontinentRepresenting approximatelyShape lifesciencesGastric balloon systemObalon balloon system